The Brand Name COMBIHALE FT REDICAPS Has Generic Salt :: Formoterol 

COMBIHALE FT REDICAPS  Is From Company DR. REDDY’S Priced :: Rs. 270

COMBIHALE FT REDICAPS have Formoterol is comes under Sub class #N/A of  Main Class #N/A

Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Formoterol    Rs. 270  1
Brand Name Company / Manufacturers Strength Unit Price / 1
 COMBIHALE FT REDICAPS  DR. REDDY’S  12MCG,18MCG/ACT.  1 Rs. 270

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From DR. REDDY’S :: COMBIHALE FT REDICAPS  Formoterol  #N/A #N/A

Indications for Drugs ::

Asthma,Chronic bronchitis, Emphysema, COPD

Drug Dose ::

Adult: Inhalation Acute bronchospasm; Reversible airways obstruction As inhalation cap: 12 mcg twice daily, up to 24 mcg twice daily in severe cases. As dry powd inhaler: 6 or 12 mcg 1-2 times/day, up to to 24 mcg twice daily in sever cases. As metered doses from aerosol inhaler: 12 or 24 mcg twice daily. Prevention of exercise-induced bronchospasm 6 or 12 mcg at least 15 mins before exercise. Additional doses may be given 12 hr later.

Contraindication ::

Hypersensitivity.

Drug Precautions ::

Thyrotoxicosis; severe CV disorders e.g. ischaemic heart disease, tachyarrhythmias or severe heart burn; prolonged QT-interval. DM; pregnancy; lactation; children <5 yr; do not initiate or increase the dose during an exacerbation. May produce paradoxical bronchospasm. Drug Side Effects ::

Tremor, headache, tiredness, restlessness, dizziness, dry mouth, palpitation, tachycardia, muscle cramps, nausea.

Pregnancy category ::
Pregnancy category

3

Drug Mode of Action ::  

Formoterol relaxes the bronchial smooth muscle by selectively acting on ?2-receptors with minimal effect on heart rate. It has a long-acting effect.

Drug Interactions ::

Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a possible hypokalaemic effect of ?-agonists. Increased susceptibility to cardiac arrhythmias in patients treated with digitalis. Concomitant use with quinidine, disopyramide, procainamide, phenothiazines, antihistamines, MAOI or TCAs can prolong the QT-interval and increase the risk of ventricular arrhythmias. L-dopa, L-thyroxine, oxytocin and alcohol can impair cardiac tolerance towards ?2-sympathomimetics. ?-adrenergic blockers can inhibit the effect of formoterol. Increased risk of arrhythmias in patients receiving concomitant anaesthesia with halogenated hydrocarbons.

 

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
{{ reviewsOverall }} / 5 Users (0 votes)
Rating0
What people say... Leave your rating
Order by:

Be the first to leave a review.

User Avatar User Avatar
Verified
{{{ review.rating_title }}}
{{{review.rating_comment | nl2br}}}

Show more
{{ pageNumber+1 }}
Leave your rating